Showing results (1971-1980 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|April 5, 2000
Economic cost of male erectile dysfunction using a decision analytic model: for a hypothetical managed-care plan of 100,000 membersH L TanPharmacoeconomics|November 11, 1999
Patient-level estimates of the cost of complications in diabetes in a managed-care populationS D Ramsey, K Newton, D Blough, et al.Pharmacoeconomics|January 9, 2001
The epidemic of Alzheimer's disease. How can we manage the costs?N Johnson, T Davis, N BosanquetPharmacoeconomics|January 9, 2001
Glipizide. A review of the pharmacoeconomic implications of the extended-release formulation in type 2 diabetes mellitusR H Foster, G L PloskerPharmacoeconomics|November 7, 2000
Clinical trials and the new good clinical practice guideline in Japan. An economic perspectiveS Ono, Y KodamaPharmacoeconomics|January 6, 2000
Cochrane reviews and systematic reviews of economic evaluations. Amantadine and rimantadine in the prevention and treatment of influenzaT Jefferson, V Demicheli, D Rivetti, et al.Pharmacoeconomics|February 1, 2003
NICE methodological guidelines and decision making in the National Health Service in England and WalesAmiram Gafni, Stephen Birch, , et al.Pharmacoeconomics|February 1, 2003
Treatment of atopic dermatitis and impact on quality of life: a review with emphasis on topical non-corticosteroidsRoman Schiffner, Julia Schiffner-Rohe, Michael Landthaler, et al.Pageof 336